A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada

NCT03958799 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Tetanus Immunisation (Healthy Volunteers)
Diphtheria Immunisation (Healthy Volunteers)
Pertussis Immunisation (Healthy Volunteers)

Interventions

BIOLOGICAL: Investigational Tdap vaccine Formulation B
BIOLOGICAL: Investigational Tdap vaccine Formulation C
BIOLOGICAL: Investigational Tdap vaccine Formulation A
BIOLOGICAL: Investigational Tdap vaccine Formulation D
BIOLOGICAL: Licensed Tdap vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company